Skip to content
thestock.space

Divi's Laboratories vs Laurus Labs: share price, P/E, ROE and financials compared

Prices as of 6 Nov 2026. Figures are from company filings and exchange data. This is an educational comparison, not investment advice.

Divi's Laboratories

NSE: DIVISLAB · Healthcare

₹10,320.50plus 1.78%

Laurus Labs

NSE: LAURUSLABS · Healthcare

₹2,340.00minus 0.26%

Divi's Laboratories and Laurus Labs at a glance

Divi's Laboratories and Laurus Labs are both listed in Healthcare. Divi's Laboratories is the larger by market cap, at ₹2.7L Cr against ₹1.3L Cr for Laurus Labs (2.2 times as large). On valuation, Divi's Laboratories has the lower price-to-book (16.35× against 20.86×). On returns and margins, Divi's Laboratories has the higher operating margin (34.9% against 30.4%), while Laurus Labs has the higher ROE (24.0% against 16.2%). Over three years, Divi's Laboratories has faster 3-year sales growth (+11.0% against +3.8% a year) and faster 3-year profit growth (+12.1% against +4.0% a year). Divi's Laboratories carries less debt for its equity, with a debt-to-equity of 0.00× against 0.42×.

Key metrics, side by side

Key metrics of Divi's Laboratories and Laurus Labs
MetricDivi's LaboratoriesDIVISLABLaurus LabsLAURUSLABS
Price (₹)10,320.502,340.00
Market cap (₹ Cr)2,73,9771,26,433
P/E93.6×94.4×
P/B16.35× (the lower figure, shaded)20.86×
Dividend yield, trailing0.29% (the higher figure, shaded)0.05%
ROE16.2%24.0% (the higher figure, shaded)
ROCE19.0%19.5%
Operating margin (OPM)34.9% (the higher figure, shaded)30.4%
Net margin (NPM)26.0% (the higher figure, shaded)17.1%
Sales CAGR 3Y+11.0% (the higher figure, shaded)+3.8%
Profit CAGR 3Y+12.1% (the higher figure, shaded)+4.0%
Debt to equity0.00× (the lower figure, shaded)0.42×
Interest cover148.3× (the higher figure, shaded)8.3×
Net profit TTM (₹ Cr)–1,340
1Y return+49.0%+138.6% (the higher figure, shaded)
Promoter holding51.88%27.47%

Shaded: the company with the more favourable reading (lower P/E, debt or P/B; higher ROE, ROCE, margins, growth or yield) when the gap is meaningful. n/m means not meaningful, for example ROCE for a bank. Loss-making companies’ multiples are shown but not ranked.

Divi's Laboratories vs Laurus Labs: common questions

Which is bigger, Divi's Laboratories or Laurus Labs?

By market cap, Divi's Laboratories is bigger at ₹2.7L Cr, against ₹1.3L Cr for Laurus Labs (prices as of 6 Nov 2026).

Which has a lower P/E ratio, Divi's Laboratories or Laurus Labs?

Divi's Laboratories trades at a P/E of 93.6× and Laurus Labs at 94.4×. The two are close. P/E is the share price divided by earnings per share; it varies a lot between industries and with growth, so it says little on its own.

Which has a higher ROE, Divi's Laboratories or Laurus Labs?

Divi's Laboratories reports a return on equity of 16.2% and Laurus Labs 24.0%. Laurus Labs has the higher ROE. ROE is net profit as a share of shareholders’ equity.

Which is growing faster, Divi's Laboratories or Laurus Labs?

Over the last three years: Sales grew +11.0% a year at Divi's Laboratories and +3.8% at Laurus Labs, so Divi's Laboratories grew sales faster; profit grew +12.1% a year at Divi's Laboratories and +4.0% at Laurus Labs, so Divi's Laboratories grew profit faster. Past growth doesn’t predict future growth.

Go to the stock pages for Divi's Laboratories and Laurus Labs, or add up to four more companies in the interactive comparison.